preinvasive

preinvasive

 [pre″in-va´siv]
not yet invading tissues outside the site of origin.

preinvasive

/pre·in·va·sive/ (pre″in-va´siv) not yet invading tissues outside the site of origin.

preinvasive

(prē″ĭn-vā′sĭv) [″ + in, into, + vadere, to go]
Referring to a stage of development of a malignancy in which the neoplastic cells have not metastasized.

preinvasive

not yet invading tissues outside the site of origin.
References in periodicals archive ?
Many studies have identified three preinvasive lesions of pancreatic cancer: pancreatic intraepithelial neoplasia (PanIN), intraductal papillary mucinous neoplasms (IPMN), and mucinous cystic neoplasms (MCN), among which pancreatic intraepithelial neoplasia lesions are the most common and most well characterized.
21) The progressive accumulation of molecular alterations in support of a preinvasive carcinoma has led some authors to prefer the term medullary carcinoma in situ or C-cell dysplasia over neoplastic CCH because it better reflects its true biologic nature.
Sequential p53 mutation analysis of preinvasive and invasive head and neck squamous carcinoma.
The association between HIV and invasive cervical cancer (ICC) is complex, with several studies now demonstrating an increased risk of preinvasive cervical lesions among HIV-positive women.
THE ULTIMATE GOAL OF CERVICAL CANCER SCREENING is to minimize unnecessary procedures while maximizing identification of preinvasive disease.
Local data from Africa on the relationship between oncogenic HPV types, immune status and cervical preinvasive lesions are also incomplete.
Patterns of Care With Regard to Surgical Choice and Application of Adjuvant Radiation Therapy for Preinvasive and Early Stage Breast Cancer in Rural Appalachia.
The frequency of the transition of dysplasia into preinvasive carcinoma is 40-64%.
Preinvasive cervical intraepithelial neoplasia 2 and 3 and adenocarcinoma in situ (together referred to as CIN2+), which are detected through routine screening, take less time to develop and were used as a surrogate for cervical cancer in vaccine trials.
HPV cervicitis is a causal risk factor for condyloma acuminatum, preinvasive cervical intraepithelial neoplasia (CIN 1, 2, 3) and eventually cancer [2] Carcinoma of the female genital tract particularly cancer of cervix accounts for almost 2% all cancers in women, and so represents the second most frequent gynaecological malignancy in the world.